These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6337096)

  • 1. Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors.
    Wexler DE; Nelson RD; Cleary PP
    Infect Immun; 1983 Jan; 39(1):239-46. PubMed ID: 6337096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin bound to the surface of M protein-positive streptococci increased their phagocytosis by human polymorphonuclear leukocytes in the absence of complement and bactericidal antibodies.
    Wagner B; Schmidt KH; Wagner M; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Jul; 261(4):432-46. PubMed ID: 3532629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
    Pandiripally V; Gregory E; Cue D
    Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of subinhibitory concentrations of josamycin on the expression of M protein by group A streptococci.
    Lam C; Basalka E
    Eur J Clin Microbiol; 1985 Jun; 4(3):279-81. PubMed ID: 3894016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling.
    Weineisen M; Sjöbring U; Fällman M; Andersson T
    J Immunol; 2004 Mar; 172(6):3798-807. PubMed ID: 15004185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
    Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
    J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
    Dale JB; Washburn RG; Marques MB; Wessels MR
    Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease.
    Oda T; Kojima Y; Akaike T; Ijiri S; Molla A; Maeda H
    Infect Immun; 1990 May; 58(5):1269-72. PubMed ID: 1691142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic response of equine polymorphonuclear leucocytes to Streptococcus equi.
    Muhktar MM; Timoney JF
    Res Vet Sci; 1988 Sep; 45(2):225-9. PubMed ID: 3194592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of chemotaxins and opsonins to neutrophil-mediated killing of Schistosoma mansoni larvae.
    King CH; Spagnuolo PJ; Ellner JJ
    Infect Immun; 1986 Jun; 52(3):748-55. PubMed ID: 3011674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of the group A streptococcal C5a inactivator.
    Wexler DE; Chenoweth DE; Cleary PP
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8144-8. PubMed ID: 3906656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic activity of polymorphonuclear leukocytes to Streptococcus pyogenes.
    Tylewska S; Kłosińska-Kita E; Malinowski W
    Zentralbl Bakteriol Orig A; 1978 Sep; 241(3):294-300. PubMed ID: 364883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.
    Whitnack E; Beachey EH
    J Exp Med; 1985 Dec; 162(6):1983-97. PubMed ID: 3906018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells.
    Courtney HS; Liu S; Dale JB; Hasty DL
    Infect Immun; 1997 Jun; 65(6):2472-4. PubMed ID: 9169794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
    Johnsson E; Berggård K; Kotarsky H; Hellwage J; Zipfel PF; Sjöbring U; Lindahl G
    J Immunol; 1998 Nov; 161(9):4894-901. PubMed ID: 9794423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.